Tag: sickle cell disease
CSL Behring buys US biotech company Calimmune
CSL Behring, the major operating arm of the CSL Group, has agreed to acquire US Biotechnology company Calimmune, Inc. for an upfront payment of...
Featured Article
Why energy is becoming a strategic asset for manufacturers
Energy is no longer just a cost centre for manufacturers – it is fast becoming a strategic lever for efficiency, resilience and growth.
